Democratic Lawmakers File Bill To Federally Legalize Marijuana As Trump Weighs Rescheduling

As the Trump administration considers rescheduling marijuana, Congressional Democrats have filed a bill to federally legalize cannabis by descheduling it altogether.

In addition to removing the drug from the Controlled Substances Act (CSA), the new legislation also contains a variety of provisions meant to promote equity and address the collateral consequences of prohibition.

On Friday, Rep. Jerrold Nadler (D-NY), reintroduced the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, alongside three dozen cosponsors.

This is the fourth session in a row that Nadler has put forward the proposal. It passed the House twice under Democratic control while the sponsor served as chairman of the Judiciary Committee, but it did not advance last session with Republicans in the majority.

“As more states continue to legalize marijuana and public support increases, federal laws must catch up and reverse failed policies criminalizing marijuana,” Nadler said in a press release. “It is long past time to decriminalize marijuana at the federal level, expunge marijuana convictions, and facilitate resentencing, while reinvesting in the communities most adversely impacted by the War on Drugs.”

Despite uncertainty about its prospects of advancing this Congress—especially at a time when President Donald Trump is actively considering a more modest proposal to simply reschedule cannabis—advocates are again touting the MORE Act as an example of the type of wide-ranging cannabis reform legislation would take necessary steps to right the wrongs of prohibition and promote social equity.

The latest version of the legislation is largely consistent with past iterations, with certain technical changes including updated data in its findings section, for example.

Keep reading

Czech Republic Bill To Legalize Marijuana Home Cultivation And Allow Psilocybin For Medical Use Heads To President’s Desk

Lawmakers in the Czech Republic have passed a bill to reform the nation’s drug laws by legalizing simple possession and home cultivation of marijuana and allowing the use of psilocybin for medical purposes.

One month after the Chamber of Deputies approved the legislation, the Senate gave it final approval on Thursday. It now heads to the desk of President Petr Pavel to be signed into law.

The drug policy reforms are part of a package of amendments to the Czechia’s criminal code that supporters say will reduce spending on low-priority offenses, lower the number of people behind bars and reduce recidivism.

“The amendment will help criminal law better distinguish between truly socially harmful behavior and cases that do not belong in criminal proceedings at all,” outgoing Justice Minister Pavel Blažek said last month, according to a translated report from broadcaster Česká Televize (CT).

With respect to cannabis, the proposal would legalize possession of up to 100 grams of marijuana at home or 25 grams in public. Cultivation of up to three plants would also be allowed, though four or five plants would be a misdemeanor and more than that would be a felony. Possession of more than 200 grams would also carry criminal penalties.

Keep reading

Attorney Says Just One Signature Could Federally Reschedule Cannabis

In a newly published legal analysis, Denver-based attorney and international drug policy expert Jason Adelstone outlines a compelling case that the U.S. Attorney General has the authority to unilaterally reschedule marijuana—without needing approval from Congress or input from health agencies.

Adelstone points to a rarely discussed provision of federal law, 21 U.S.C. § 811(d)(1), that grants the Attorney General the authority to reschedule substances in order to comply with international treaty obligations. Unlike the more commonly cited rescheduling process involving the Department of Health and Human Services, this statute allows for swift, unilateral executive action.

“All it would take is a press release and a pen,” Adelstone writes, noting that current Attorney General Pam Bondi could shift marijuana from Schedule I to a lower schedule—such as Schedule III—immediately, citing treaty compliance with the Single Convention on Narcotic Drugs. That move would eliminate the burdensome IRS tax code provision 280E, which prevents legal marijuana businesses from deducting ordinary expenses.

While litigation would likely follow, Adelstone argues the statutory authority is clear and would remain in effect during court proceedings. He also warns that the same provision could be used in reverse—a future Attorney General could place marijuana back into Schedule I without Congressional input, highlighting the instability of relying solely on executive action.

“The real solution lies with Congress,” Adelstone concludes. “Only a legislative fix can provide durable protection from policy reversals and regulatory uncertainty.”

Adelstone also criticizes the marijuana industry’s lobbying efforts, calling them largely ineffective despite millions spent. He suggests a more politically strategic approach is necessary—one that acknowledges how Washington works and adjusts accordingly.

A longtime advisor on cannabis law and international policy, Adelstone has worked with U.S. and global stakeholders on regulatory issues surrounding marijuana reform. His latest analysis throws new weight behind the argument that one signature could ignite sweeping change—but that only Congress can make it last.

Keep reading

Marijuana Opponents ‘Have Lost’ The Debate, GOP Senator Says, Arguing ‘It’s Time’ To Regulate It Like Alcohol And Tobacco

A GOP senator says opponents of marijuana legalization “have lost” the fight to maintain prohibition and that “it’s time” for lawmakers to address that reality by creating a regulatory framework treating cannabis “in the same way that we do with alcohol and tobacco,” so that states can set their own policies without federal intervention.

During a Senate Judiciary Committee hearing on Tuesday that featured witnesses from the Drug Enforcement Administration (DEA), Department of Homeland Security (DHS) and the Federal Bureau of Investigation (FBI), Sen. Thom Tillis (R-NC) pressed the DEA representative on cannabis policy issues.

“I have tried to keep pounding the table and saying, ‘Folks, those of us who were not necessarily eager to legalize pot have lost,’” the senator said. “The majority of states have legalized it at some level or another. I don’t really have a whole lot of emotions about it personally, but for the fact that I don’t think we’re regulating it properly, and I do believe it’s just become another distribution channel for the cartels.”

Tillis seemed to be arguing that the absence of federal regulations, and the policy disconnect with states that have increasingly enacted legalization, has created a vacuum that’s allowed illicit operators to thrive.

“We’ve got to get this under control. We have to realize that pot is going to be legal in this country in one form or another, and virtually every other state,” he said. “We can either figure out how to regulate it by putting a U.S. Department of Agriculture regimen in [and] an [Food and Drug Administration, or FDA] regimen in the same way that we do with alcohol and tobacco are.”

Keep reading

Veterans deserve change. US should reschedule cannabis now.

When our nation’s heroes return home, they often face a quiet suffering — something I have seen happen so often in my peers. As a combat veteran and an advocate for those who have worn the uniform, I know that so many of us face these challenges long after we return home. Post-traumatic stress (PTS) is a battlefield of its own — invisible, relentless, and too often fought alone.

Over the years, I’ve dedicated my life to improving the lives of our veterans, whether serving as a Veterans Fellow and Lead Policy Advisor on Military and Veterans Affairs to Sen. Chuck Grassley, leading within the Iowa Veterans of Foreign Wars (VFW), or conducting academic research focused on veterans’ issues. One thing has become undeniably clear: it’s time to reschedule cannabis as a Schedule III substance under federal law, a change that is backed by President Donald Trump, which would open the door for unlocking its therapeutic potential for veterans suffering from PTS and other chronic illnesses.

Currently, cannabis remains a Schedule I substance — the same category as heroin — defined as having “no accepted medical use” and a “high potential for abuse.” This is not only scientifically outdated, but also morally indefensible. Veterans are not asking for a miracle cure. We are asking for options. We are asking for the freedom to explore alternative treatments when conventional therapies — prescription medications, talk therapy, or exposure therapy — fall short. For many veterans, they do. And for some, cannabis has helped where nothing else has.

Keep reading

Trump’s Federal Budget Cuts Could Boost Marijuana Legalization Efforts As States Seek New Revenue, Congresswoman Says

A Democratic congresswoman says the Trump administration’s push to make states pay a larger share for public services such as food assistance and health care amid his efforts to cut federal spending might ultimately “push them in the direction of legalizing marijuana” so they can offset those costs with cannabis tax revenue.

In an interview on the National Cannabis Industry Association (NCIA) Voice of Cannabis podcast that was released on Thursday, Congressional Cannabis Caucus co-chair Rep. Dina Titus (D-NV) commented on a wide range of marijuana policy issues—including bipartisan legalization legislation, stalled action on federal reform and the destigmatization of cannabis use in her state after enacting an adult-use marijuana market.

One of the “only good things that comes out of the policy of the White House is that they are pushing more things to the states to pay for—like [Supplemental Nutrition Assistance Program (SNAP)] and like Medicaid—and so states may be looking for additional sources of revenue,” Titus said. “That may push them in the direction of legalizing marijuana, to some extent, so they can get that tax revenue generated.”

Titus said the lawmakers who back reform were initially “optimistic” about the prospects of a federal policy change under President Donald Trump because of comments he made on the campaign trail in favor of rescheduling, industry banking access and a Florida adult-use legalization ballot initiative left the impression “he was going to be supportive.”

“Now we’ve seen that kind of stall, and we have this crazy secretary of [the U.S. Department of Health and Human Services (HHS)] that I think is on drugs,” the congresswoman said, referencing Robert F. Kennedy Jr. “I don’t know where he’s coming from, and so it’s hard to read what the administration is going to do and if they’re going to make it a priority and if they’re going to weigh in. So that’s another element of the politics that we have to keep in mind.”

Keep reading

Hotels See Significant Boost In Revenue Following Marijuana Legalization, New Study Shows

A new study exploring the impacts of adult-use marijuana legalization on the hospitality industry finds that “hotel revenue increases by 25.2% (or $63,671 monthly) due to dispensary legalization, with the effect continuing to grow even six years after legalization.”

The research article, published in the journal Production Operations and Management (POMS), draws its inferences from a review of data from Colorado, which authors say saw “a 7.9% increase in room night bookings and a 16.0% rise in daily room rates,” though impacts varied based on a number of factors.

“These findings are relevant for professionals in marketing, operations management, hospitality, tourism, and public policy,” the study says, noting that the “rapid expansion of the marijuana business presents both opportunities and challenges for the hotel industry.”

“On the one hand, recreational marijuana dispensaries could become attractions that entice travelers to visit places they might not otherwise explore. For instance, around 12% of US tourists have reported positive experiences with marijuana-related travel… On the other hand, the lingering social stigma surrounding marijuana could negatively affect businesses, including hotels, located near these dispensaries. This concern is underscored by a Colorado Office of Economic Development and International Trade (OEDIT 2019) report, which found that about 10% of US leisure travelers view Colorado as a less desirable destination because of recreational marijuana.”

Despite the apparently polarized feelings around traveling to jurisdictions where marijuana is legal, the study found that hotels seemed to perform better following the policy change.

Comparing hotels in Colorado to hotels in New Mexico, where cannabis was illegal during the study period, the team’s analysis found that “on average, monthly hotel revenue increases by 25.2% upon the legalization of recreational marijuana dispensaries, which is equivalent to a substantial increase of $63,671 per hotel.”

Keep reading

Pennsylvania Senator Announces New Marijuana Legalization Bill After Committee Defeats House-Passed Reform Proposal

A Pennsylvania Democratic senator has announced his intent to file a new bill to legalize marijuana in the state, calling on colleagues to join him on the measure days after a Senate committee killed a separate House-passed proposal to enact cannabis legalization with state-run stores.

In a cosponsorship memo circulated last week, Sen. Marty Flynn (D) said his bill would establish a “responsible framework for cultivation, distribution, and retail sales to adults aged 21 and over,” indicating that the legislation will follow a more conventional regulatory model for cannabis.

“This legislation represents a commonsense opportunity to modernize our cannabis laws by delivering lasting economic benefits to communities across the Commonwealth while balancing individual liberty with public safety,” he said of the bill, which will be called the Keystone Cannabis Act.

Notably, Flynn put out an earlier cosponsorship memo in 2022 that detailed a bill he said he’d be introducing that would have sought to legalize marijuana through a state-run model, similar to the legislation that narrowly advanced through the House only to be rejected in a Senate committee last week.

The new memo signals his forthcoming legislation will steer clear of the controversial proposal, placing regulatory responsibility in the hands of the state Departments of Health, Agriculture and Community and Economic Development, as well as the attorney general and state police.

It would also create a Commonwealth Community Reinvestment and Infrastructure Fund, using marijuana tax revenue—which Flynn estimates will be upwards of $500 million annually—to support the revitalization of rural areas, infrastructure initiatives and local grants for “law enforcement, public health, and educational programs focused on substance use prevention and mental health.”

There would also be equity components embedded in the measure, including provisions that would prioritize cannabis business licensing for those from communities disproportionately impacted by prohibition and creating a pathway for expunging past marijuana records.

Keep reading

GOP Senator Who Opposes Marijuana Legalization Complains About Federal Alcohol Guidelines Recommending Americans Drink Less

A GOP senator is complaining about pending revisions to federal guidelines that could recommend Americans drink less alcohol, even as he maintains his strong opposition to legalizing marijuana.

As the Substance Abuse and Mental Health Services Administration (SAMHSA) works to finalize updated dietary guidance for Americans, which will be partly informed by a study that some expect will recommend further reducing alcohol intake, Sen. Tom Cotton (R-AR) is standing strong in defense of alcohol’s legal status.

“Wasting taxpayer dollars on studies to ban alcohol is exactly why [former President Joe Biden] and his cronies were voted out of the White House,” he told The Washington Reporter.

To be clear, the study that’s being carried out by SAMHSA’s Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) isn’t intended to impose a “ban” on alcohol. Rather, it’s meant to provide updated data on the potential risks of alcohol use, with findings that could be incorporated into the 2025 Dietary Guidelines for Americans, which is not legally binding for consumers.

But Cotton’s comment reflects a policy disconnect that has long frustrated cannabis reform advocates who’ve long argued that, if alcohol is legal and regulated, it’s nonsensical to continue prohibiting marijuana, which many studies show is comparably safer and therapeutically beneficial for many patients.

If pursuing a ban on alcohol is a waste of taxpayer dollar, as the senator suggested, it’s notable he doesn’t feel similarly about the millions of dollars that continue to be spent arresting, prosecuting and incarcerating people over cannabis. But instead, Cotton has long maintained opposition to legalizing marijuana, including through an initiative to end cannabis prohibition that appeared on Arkansas’s 2022 ballot.

While he said in 2018 that he respected the will of voters in his state to legalize medical cannabis, he didn’t think the federal government should as much as decriminalize it. And in 2023, he sharply criticized then-Senate Majority Leader Chuck Schumer (D-NY) for proposing criminal justice provisions he wanted to add to a bipartisan marijuana banking bill, claiming Schumer was supporting “letting drug traffickers out of prison.”

In any case, Cotton isn’t the first senator to take a conflicting position on alcohol and marijuana as it concerns the SAMHSA study. Sen. Ted Cruz (R-TX), another staunch cannabis prohibition, made headlines in 2023 said that federal officials “can kiss my ass” if they decide to reduce the recommended maximum consumption of alcohol to two drinks per week.

“What is it with liberals and wanting to control every damn aspect of your life?” he said during an interview with Newsmax.

Keep reading

The New Hampshire Senate Has Rejected Every Marijuana Bill Passed By The House This Session

The New Hampshire Senate on Thursday moved to scuttle two marijuana measures already passed by the House, including a proposal to allow medical cannabis businesses to cultivate in greenhouses and a separate bill to expand the state’s annulment process for past arrest and conviction records.

Senators also voted to delay consideration until next month of a separate bill that would decriminalize small amounts of psilocybin.

The actions reflect the chamber’s broad hostility toward drug reform measures this session. While a number of bills cleared the House of Representatives—including to legalize adult-use marijuana and allow medical marijuana patients to grow cannabis at home—nearly all have gone on to die in the Senate.

“These outcomes are disappointing, but unfortunately, they aren’t surprising,” Matt Simon, director of public and government relations at the medical marijuana provider GraniteLeaf Cannabis, told Marijuana Moment.

Earlier this year, Simon said it appeared “that a few senators just want to kill every bill that deals with cannabis policy, no matter how modest and non-controversial.”

All told, senators have now moved to table or kill eight House-passed measures related to marijuana this session.

One of the bills taken up at Thursday’s Senate floor session—HB 301, from Rep. Suzanne Vail (D)—would have allowed medical marijuana operators (known in the state as alternative treatment centers, or ATCs) to each establish a single additional cultivation location, including in a greenhouse.

Under current law, all growing by ATCs must happen indoors, with greenhouse cultivation prohibited.

Though House lawmakers passed the bill in February, a Senate committee earlier this month marked the proposal “inexpedient to legislate,” effectively recommending it be abandoned. On Thursday, senators voted to table it.

Simon noted that in New Hampshire, there’s strong support for broader legalization of marijuana, “so it’s hard to understand why letting ATCs grow in secure greenhouses is even remotely controversial.”

Keep reading